CYC just proving the value of an established technology that is de-risked. No need for further trials. CT/VQ is thus far just an idea. Good in theory. If someone can post some head to head comparisons of diagnostic yield for PE with v/q, ctpa and CT/vq that would be VERY compelling. Afaik they don't exist. 4Dx should have run at least this pilot work by now but the story for this company always is well ahead of the reality. Where is all the $ from using simple fluoroscopy to replace spirometry to measure lung function. This was the IPO story and it has fallen by the wayside. 56c may still be a price worth a punt but not for me. Gltah, dyor.
4DX Price at posting:
57.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)